Published in J Dermatol Surg Oncol on August 01, 1978
Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years. Strahlenther Onkol (2010) 0.85
Systematic review of non-surgical treatments for early dupuytren's disease. BMC Musculoskelet Disord (2016) 0.75
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia (2011) 4.47
Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol (1991) 2.07
The human peripheral lymphocyte--a model system for studying the combined effect of psoralen plus black light. Klin Wochenschr (1977) 1.97
The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol (1994) 1.94
[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulagaris. I. The clinically normal appearing skin in the environment of blisters with a positive Nikolski phenomenon]. Arch Klin Exp Dermatol (1965) 1.94
Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch (1974) 1.81
[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulgaris. II. The acantholytic vesicle]. Arch Klin Exp Dermatol (1965) 1.75
Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion. Br J Haematol (2001) 1.68
Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol (2002) 1.67
[Dynamics of normal and pathological hair growth]. Arch Klin Exp Dermatol (1966) 1.62
[On the problem of optimal reacting conditions in the histochemical demonstration on enzymes of the energy-delivering metabolism in the epidermis. I. Dehydrogenase]. Arch Klin Exp Dermatol (1965) 1.60
[Microstructure of the epidermis in chronic nummular eczema. I. Stratum basale]. Arch Klin Exp Dermatol (1965) 1.54
[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. Hautarzt (1990) 1.54
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. Clin Cancer Res (2001) 1.51
[Stimulation of epidermal DNA syntgesis through vitamin A acid]. Arch Klin Exp Dermatol (1968) 1.48
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study. Leukemia (2008) 1.46
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project. Leukemia (2012) 1.43
Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43
Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol (1995) 1.41
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
[Abnormal behavior of epidermal regeneration in patients with psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.39
Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies. Support Care Cancer (2003) 1.39
Acne fulminans: investigation of acute febrile ulcerative acne. Arch Dermatol (1977) 1.39
[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38
Semiquantitative analysis of histologic criteria in thin malignant melanomas. J Am Acad Dermatol (1989) 1.38
[Epidermal regeneration of guinea pig's ear following the tearing off of the horny layer. A radioautographic study]. Arch Klin Exp Dermatol (1967) 1.38
A gene expression signature for high-risk multiple myeloma. Leukemia (2012) 1.36
Prognostic index in malignant melanoma. Arch Dermatol (1978) 1.36
Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma. Cancer (1989) 1.35
[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplant (2006) 1.29
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield. Leukemia (2007) 1.28
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma. Bone Marrow Transplant (2005) 1.27
[Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris]. Hautarzt (1976) 1.27
[Modification of epidermal differentiation by vitamin A acid. Electron microscopy study]. Arch Klin Exp Dermatol (1970) 1.25
Initial events in psoriasis: quantitative assessment. Br J Dermatol (1973) 1.24
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Mechanisms of parakeratosis. Br J Dermatol (1970) 1.22
Proliferative cells in the human sebaceous gland. Labelling index and regional variations. Acta Derm Venereol (1971) 1.21
Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma. Oncogene (2006) 1.21
[The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch (1971) 1.20
[Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol (1970) 1.19
Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol (1987) 1.17
Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study. Br J Cancer (2009) 1.17
[The morphogenesis of senile actinic elastosis. An electron microscopic study]. Arch Klin Exp Dermatol (1969) 1.16
[Normal pH value of human skin]. Hautarzt (1986) 1.16
[Electron microscopic studies of the dynamics of blister formation in bullous pemphigoid]. Arch Klin Exp Dermatol (1967) 1.15
[On the histotopy of enzymes of energy producing metabolism in the epidermis in psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.15
[Distribution of acid phosphatase in normal and psoriatic keratinization. (Electron microscopic and cytochemical studies)]. Dermatologica (1967) 1.14
[Trichostasis spinulosa]. Hautarzt (1967) 1.13
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood (1994) 1.13
[Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test]. Hautarzt (1977) 1.12
[On histochemical enzyme demonstration in skin pathogenic fungi. II. Dermatophytes]. Arch Klin Exp Dermatol (1966) 1.11
[Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis]. Hautarzt (1977) 1.11
[Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol (1970) 1.11
Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet (1991) 1.11
[On the enzymatic organization of the energy producing metabolism of normal guinea pig skin. 3. Activity determination of epidermal enzymes of the citric acid cycle and associated reactions]. Arch Klin Exp Dermatol (1966) 1.10
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. Oncogene (2009) 1.10
[On quantitative assessment of histochemical dehydrogenase demonstrations]. Histochemie (1965) 1.10
Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol (1989) 1.09
Diffuse and banded melanin pigmentation in nails. Arch Dermatol (1972) 1.09
Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma. Leukemia (2002) 1.09
The dermal inflammatory reaction in initial psoriatic lesions. Arch Dermatol Res (1977) 1.09
[On the thickness of collagen fibrils in the embryonal skin]. Z Zellforsch Mikrosk Anat (1967) 1.09
Reactivity of T cells in mycosis fungoides exhibiting marked epidermotropism with the monoclonal antibody HML-1 that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol (1989) 1.09
[On the histotopy of ubiquinone in human skin. I. Normal skin]. Arch Klin Exp Dermatol (1966) 1.08
Treatment of alopecia areata by anthralin-induced dermatitis. Arch Dermatol (1979) 1.07
Pseudopelade of Brocq. Dermatologica (1986) 1.06
Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation. Br J Haematol (1999) 1.06
Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents. Ann Oncol (2014) 1.05
Psoriatic hyperplasia: some measurements. Br J Dermatol (1970) 1.05
[Ultrastructure of dermal changes in human allergic skin test reaction]. Arch Dermatol Forsch (1971) 1.05
UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen. Br J Dermatol (1977) 1.04
Reactions to ionizing radiation. J Am Acad Dermatol (1980) 1.04
Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol (2003) 1.04
[On the effect of the epilation technic on the normal and pathologic hair root pattern]. Arch Klin Exp Dermatol (1965) 1.04
Dermatitis associated with an implanted cardiac pacemaker. Arch Dermatol (1970) 1.03
Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation. Leukemia (2010) 1.03
Virus-like particles in the hamster melanoma A Mel 3 of fortner. Naturwissenschaften (1970) 1.03
Lectin typing of Haemophilus ducreyi. Eur J Clin Microbiol Infect Dis (1988) 1.02
[Ultrastructural changes of the epidermis in allergic patch test reaction]. Arch Dermatol Forsch (1970) 1.02
[On the behavior of autoantibodies in bullous pemphigoid]. Hautarzt (1967) 1.01
[RNA-synthesis of the skin. DNA-dependent RNA-polymerase activity in guinea pig epidermis]. Arch Klin Exp Dermatol (1970) 1.01
Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading. Am J Pathol (1989) 1.01
Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. J Invest Dermatol (1978) 1.01
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas. Bone Marrow Transplant (2004) 1.00
[On the problem of optimal reaction conditions in the histochemical demonstration of enzymes of energy-producing metabolism in the epidermis. II. Aldolase, tetrazolium reductase, cytochrome oxidase, ubiquinone]. Arch Klin Exp Dermatol (1966) 1.00
Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. Acta Derm Venereol (1990) 1.00
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
[Pagetoide reticulosis--Woringer-Kolopp's disease]. Hautarzt (1973) 0.99
Steatocystoma multiplex: anatomic reevaluation, electron microscopy, and autoradiography. Arch Dermatol Res (1982) 0.99
[Morphologic variants of genital ulcer caused by Haemophilus ducreyi]. Hautarzt (1989) 0.99
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer (2001) 0.99
High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis. Leukemia (2003) 0.99
[Hereditary and non-hereditary form of chronic hepatic porphyria: different behaviour of uroporphyrinogen decarboxylase in liver and erythrocytes (author's transl)]. Klin Wochenschr (1980) 0.98
[Treatment of oligospermia with amitriptyline]. Munch Med Wochenschr (1971) 0.98
[Quantitative behavior of immunoglobulins and complement in psoriasis. Importance of immune factors in psoriasis]. Arch Klin Exp Dermatol (1970) 0.98
[On esterase isozymes in the horny layer of normal skin as well as in psoriasis, eczema and ichthyosis. Enzyme electrophoretic studies on exuviae extracts]. Arch Klin Exp Dermatol (1966) 0.98
Bisphosphonates in multiple myeloma. Cochrane Database Syst Rev (2002) 0.97